Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association

B Feingold, WT Mahle, S Auerbach, P Clemens… - Circulation, 2017 - Am Heart Assoc
For many neuromuscular diseases (NMDs), cardiac disease represents a major cause of
morbidity and mortality. The management of cardiac disease in NMDs is made challenging …

Treating pediatric neuromuscular disorders: the future is now

JJ Dowling, H D. Gonorazky, RD Cohn… - American Journal of …, 2018 - Wiley Online Library
Pediatric neuromuscular diseases encompass all disorders with onset in childhood and
where the primary area of pathology is in the peripheral nervous system. These conditions …

Elevated cardiac troponin T in patients with skeletal myopathies

J Schmid, L Liesinger, R Birner-Gruenberger… - Journal of the American …, 2018 - jacc.org
Background: Cardiac troponins are often elevated in patients with skeletal muscle disease
who have no evidence of cardiac disease. Objectives: The goal of this study was to …

[HTML][HTML] Myotonic dystrophy type 1

TD Bird - 2021 - europepmc.org
Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth
muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical …

Targeting myotonic dystrophy type 1 with metformin

M García-Puga, A Saenz-Antoñanzas… - International Journal of …, 2022 - mdpi.com
Myotonic dystrophy type 1 (DM1) is a multisystemic disorder of genetic origin. Progressive
muscular weakness, atrophy and myotonia are its most prominent neuromuscular features …

[HTML][HTML] Myotonic dystrophies: targeting therapies for multisystem disease

S LoRusso, B Weiner, WD Arnold - Neurotherapeutics, 2018 - Elsevier
Myotonic dystrophy is an autosomal dominant muscular dystrophy not only associated with
muscle weakness, atrophy, and myotonia but also prominent multisystem involvement …

Myotonic dystrophy type 1 management and therapeutics

CA Smith, L Gutmann - Current treatment options in neurology, 2016 - Springer
Opinion statement Myotonic dystrophy (DM1) is the most common form of adult muscular
dystrophy. It is a multisystem disorder with a complex pathophysiology. Although inheritance …

Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

GG Gutiérrez, J Díaz-Manera, M Almendrote… - … Clínica (English Edition), 2019 - Elsevier
Background and objectives Steinert's disease or myotonic dystrophy type 1 (MD1),(OMIM
160900), is the most prevalent myopathy in adults. It is a multisystemic disorder with …

Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert

GG Gutiérrez, J Díaz-Manera, M Almendrote, S Azriel… - Medicina Clínica, 2019 - Elsevier
Antecedentes y objetivos La enfermedad de Steinert o distrofia miotónica tipo 1
(DM1),(OMIM 160900) es la miopatía más prevalente en el adulto. Es una enfermedad …

[HTML][HTML] Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes

EY Kim, DY Barefield, AH Vo, AM Gacita, EJ Schuster… - JCI insight, 2019 - ncbi.nlm.nih.gov
Myotonic dystrophy (DM) is the most common autosomal dominant muscular dystrophy and
encompasses both skeletal muscle and cardiac complications. DM is nucleotide repeat …